Faculty Disclosures
|
No disclosure on file
|
| Wyatt P. Bensken |
No disclosure on file
|
| Errol L. Gordon, MD |
No disclosure on file
|
| Joana Moreira |
Joana Moreira has received personal compensation for serving as an employee of BIAL. |
| Diana Wheaton |
Diana Wheaton has received personal compensation for serving as an employee of FTD Disorders Registry. The institution of Diana Wheaton has received research support from Rainwater Charitable Foundation. The institution of Diana Wheaton has received research support from NIA. |
| Michel T. Torbey, MD, MPH, FAAN |
Dr. Torbey has nothing to disclose. |
| Miqun Robinson |
No disclosure on file
|
| Avindra Nath, MD, MBBS, FAAN |
The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care. |
| Madeline C. Fields, MD |
Dr. Fields has nothing to disclose. |
| Tetsuya Akaishi |
Mr. Akaishi has nothing to disclose. |
| Hailong Cheng |
No disclosure on file
|
| Selda Keskin Guler |
No disclosure on file
|
| Mohamad Koubeissi, MD, FAAN |
Dr. Koubeissi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. |
| Lara V. Marcuse, Sr., MD |
Dr. Marcuse has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace. |
| Ronaldo Abraham, MD |
No disclosure on file
|
| Juan Duran Quiroz, MD |
No disclosure on file
|
| Ji-Yeoun Yoo, MD |
Dr. Yoo has received publishing royalties from a publication relating to health care. |
| David E. Blum, MD |
Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics. |
| Amit Verma, MD, MBBS, FAAN |
No disclosure on file
|
| Jessica L. Coleman |
No disclosure on file
|
| Banu F. Anlar, MD |
No disclosure on file
|
| Arturo Carpio, MD |
No disclosure on file
|
| Neha Dangayach, MD, FAAN |
Dr. Dangayach has nothing to disclose. |
| Philippe Ryvlin, MD, PhD |
Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle/Angelini. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB pharma. The institution of Dr. Ryvlin has received research support from Swiss National Fund. The institution of Dr. Ryvlin has received research support from European Commission (Horizon Europe). |
| Francisco Rocha |
Francisco Rocha has received personal compensation for serving as an employee of BIAL - Portela. |
| Tahir K. Yoldas, MD |
No disclosure on file
|
| José H. Posas, MD, FAAN |
Dr. Posas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Posas has or had stock in Dane Health.Dr. Posas has or had stock in Brainscope.Dr. Posas has a non-compensated relationship as a Advisor with Dane Health that is relevant to AAN interests or activities. Dr. Posas has a non-compensated relationship as a Lecturer with Concussion Corner Academy that is relevant to AAN interests or activities. Dr. Posas has a non-compensated relationship as a Advisor with Brainscope that is relevant to AAN interests or activities. |
| Yasushi Suzuki, MD, PhD |
Yasushi Suzuki, MD, PhD has nothing to disclose. |
| Gregory W. Albers, MD |
No disclosure on file
|
| Todd Grinnell, PhD |
Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc.. |
| David G. Vossler, MD, FAAN |
Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Longboard Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. The institution of Dr. Vossler has received research support from Xenon Pharmaceuticals. The institution of Dr. Vossler has received research support from Longboard Pharmaceuticals. Dr. Vossler has received publishing royalties from a publication relating to health care. |
| Cormac A. O'Donovan, MD |
Dr. O'Donovan has nothing to disclose. |